Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

A perspective on the 2009 A/H1N1 influenza pandemic in Mexico.

Acuña-Soto R, Castañeda-Davila L, Chowell G.

Math Biosci Eng. 2011 Jan;8(1):223-38. doi: 10.3934/mbe.2011.8.223.

PMID:
21361409
2.

Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.

Prosper O, Saucedo O, Thompson D, Torres-Garcia G, Wang X, Castillo-Chavez C.

Math Biosci Eng. 2011 Jan;8(1):141-70. doi: 10.3934/mbe.2011.8.141.

PMID:
21361405
3.

Evaluation of vaccination strategies during pandemic outbreaks.

Bowman CS, Arino J, Moghadas SM.

Math Biosci Eng. 2011 Jan;8(1):113-22. doi: 10.3934/mbe.2011.8.113.

PMID:
21361403
4.

Multiple outbreaks for the same pandemic: Local transportation and social distancing explain the different "waves" of A-H1N1pdm cases observed in México during 2009.

Herrera-Valdez MA, Cruz-Aponte M, Castillo-Chavez C.

Math Biosci Eng. 2011 Jan;8(1):21-48. doi: 10.3934/mbe.2011.8.21.

PMID:
21361398
5.

Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.

Ghosh S, Heffernan J.

PLoS One. 2010 Dec 20;5(12):e14307. doi: 10.1371/journal.pone.0014307.

6.

A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics.

Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML.

J Public Health Manag Pract. 2011 Jan-Feb;17(1):E22-8. doi: 10.1097/PHH.0b013e3181f87952.

PMID:
21135651
7.

Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.

Abelin A, Colegate T, Gardner S, Hehme N, Palache A.

Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27. Review.

8.

Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009.

Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L.

CMAJ. 2010 Dec 14;182(18):1981-7. doi: 10.1503/cmaj.100746. Epub 2010 Nov 8.

9.

Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations.

Rambhia KJ, Watson M, Sell TK, Waldhorn R, Toner E.

Biosecur Bioterror. 2010 Dec;8(4):321-30. doi: 10.1089/bsp.2010.0043. Epub 2010 Nov 2.

PMID:
21043791
10.

Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination.

Lee BY, Brown ST, Cooley P, Grefenstette JJ, Zimmerman RK, Zimmer SM, Potter MA, Rosenfeld R, Wheaton WD, Wiringa AE, Bacon KM, Burke DS.

Am J Prev Med. 2010 Nov;39(5):e21-9. doi: 10.1016/j.amepre.2010.07.014.

11.

Reflections on pandemic (H1N1) 2009 and the international response.

Leung GM, Nicoll A.

PLoS Med. 2010 Oct 5;7(10). pii: e1000346. doi: 10.1371/journal.pmed.1000346. Review. No abstract available.

12.

Pandemic (H1N1) 2009: assessing the response.

Low DE, McGeer A.

CMAJ. 2010 Nov 23;182(17):1874-8. doi: 10.1503/cmaj.100900. Epub 2010 Oct 18. No abstract available.

13.

The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.

del Rio C, Guarner J.

Trans Am Clin Climatol Assoc. 2010;121:128-37; discussion 138-40. Review.

14.

Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.

Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M.

Vaccine. 2010 Aug 31;28(38):6210-20. doi: 10.1016/j.vaccine.2010.07.010. Epub 2010 Jul 17.

PMID:
20643091
15.

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets.

Partridge J, Kieny MP; World Health Organization H1N1 influenza vaccine Task Force.

Vaccine. 2010 Jul 5;28(30):4709-12. doi: 10.1016/j.vaccine.2010.04.083. Epub 2010 May 18.

PMID:
20488262
16.

Agent-based modeling of host-pathogen systems: The successes and challenges.

Bauer AL, Beauchemin CA, Perelson AS.

Inf Sci (Ny). 2009 Apr 29;179(10):1379-1389.

17.

H1N1: a Mexican perspective.

Vargas-Parada L.

Cell. 2009 Dec 24;139(7):1203-5. doi: 10.1016/j.cell.2009.12.019.

19.

Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.

Chowell G, Viboud C, Wang X, Bertozzi SM, Miller MA.

PLoS One. 2009 Dec 3;4(12):e8164. doi: 10.1371/journal.pone.0008164.

20.

Modelling mitigation strategies for pandemic (H1N1) 2009.

Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT.

CMAJ. 2009 Nov 10;181(10):673-80. doi: 10.1503/cmaj.091641. Epub 2009 Oct 13.

Supplemental Content

Support Center